Internal Medicine, Hematology & Oncology · Mission Viejo, CA
NPI
1558545038
Since 2007
Specialty
Internal Medicine, Hematology & Oncology
Code 207RH0003X
Group practices
1
Medicare group memberships
Hospitals
1
Hospital affiliations
26691 Plaza, Ste 200
Mission Viejo, CA, 92691
Phone (949) 347-0600
Groups this clinician bills Medicare through
Medicare paid, 2024
$249K
9,861 services
Medicare patients, 2024
519
Average age 77
Drug cost, 2024
$6.1M
1,379 prescriptions
Company payments, 2025
$3,495
From 50 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by George G Miranda was code G2211 (visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's), 803 times for 396 patients. In total George G Miranda billed 9,861 services in 40 codes, and Medicare paid $249K.
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-03-07.
| Code | Setting | Services | Patients | Paid per service | Medicare paid |
|---|---|---|---|---|---|
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 803 | 396 | $13.45 | $11K |
| 99214 Office E&M - Established | Office | 770 | 362 | $103.04 | $79K |
| 85025 Blood Count | Office | 736 | 248 | $7.57 | $5,571 |
| 36415 Venipuncture Blood Collection | Office | 451 | 189 | $8.57 | $3,867 |
| 99215 Office E&M - Established | Office | 256 | 108 | $144.98 | $37K |
| 96372 Injection Administration | Office | 179 | 22 | $12.27 | $2,196 |
| 80053 Clinical Chemistry | Office | 151 | 90 | $10.28 | $1,553 |
| 99213 Office E&M - Established | Office | 144 | 131 | $67.94 | $9,783 |
| 99205 Office E&M - New | Office | 73 | 73 | $169.70 | $12K |
| 85027 Blood Count | Office | 40 | 16 | $6.34 | $254 |
| 85007 Blood Count | Office | 39 | 16 | $3.62 | $141 |
| 83615 Clinical Chemistry | Office | 36 | 33 | $5.76 | $207 |
| 82728 Clinical Chemistry | Office | 20 | 20 | $13.36 | $267 |
| 83540 Clinical Chemistry | Office | 16 | 16 | $6.34 | $101 |
| 83550 Clinical Chemistry | Office | 16 | 16 | $8.57 | $137 |
By year: 2022 $216K for 10,476 services; 2023 $224K for 8,873 services; 2024 $249K for 9,861 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 85025 Blood Count | 736 | 248 | $7.57 | $5,571 |
| 36415 Venipuncture Blood Collection | 451 | 189 | $8.57 | $3,867 |
| 80053 Clinical Chemistry | 151 | 90 | $10.28 | $1,553 |
| 85027 Blood Count | 40 | 16 | $6.34 | $254 |
| 85007 Blood Count | 39 | 16 | $3.62 | $141 |
| 83615 Clinical Chemistry | 36 | 33 | $5.76 | $207 |
| 82728 Clinical Chemistry | 20 | 20 | $13.36 | $267 |
| 83550 Clinical Chemistry | 16 | 16 | $8.57 | $137 |
| 83540 Clinical Chemistry | 16 | 16 | $6.34 | $101 |
Medicare prescription drug claims, 2024
In 2024, the drug George G Miranda prescribed most often to Medicare patients was Anastrozole, with 180 prescriptions and refills. In total George G Miranda wrote 1,379 Medicare prescriptions that cost $6.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Anastrozole Generic | 180 | 529 | 58 | $4,344 |
| Xarelto Rivaroxaban | 85 | 143 | 15 | $76K |
| Revlimid Lenalidomide | 72 | 72 | Under 11 | $1.2M |
| Dexamethasone Generic | 71 | 79 | 21 | $576 |
| Hydroxyurea Generic | 54 | 155 | 14 | $2,374 |
| Prednisone Generic | 51 | 67 | 16 | $121 |
| Imbruvica Ibrutinib | 48 | 48 | Under 11 | $321K |
| Letrozole Generic | 45 | 97 | 12 | $735 |
| Lenalidomide Generic | 40 | 40 | Under 11 | $483K |
| Xtandi Enzalutamide | 39 | 39 | Under 11 | $499K |
| Tamoxifen Citrate Generic | 38 | 114 | 11 | $995 |
| Acyclovir Generic | 35 | 63 | Under 11 | $792 |
| Ondansetron Odt Ondansetron | 33 | 33 | 16 | $217 |
| Abiraterone Acetate Generic | 33 | 33 | Under 11 | $77K |
| Calquence Acalabrutinib Maleate | 31 | 31 | Under 11 | $277K |
Brand drugs: 538 claims; generic drugs: 841 claims; opioid claims: 18.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid George G Miranda $3,495 ($3,495 in general payments such as food, travel and fees) from 50 companies. The largest payer was AstraZeneca Pharmaceuticals LP with $316.
| Company | Payments | Amount |
|---|---|---|
| AstraZeneca Pharmaceuticals LP AZN | 12 | $316 |
| Merck Sharp & Dohme LLC MRK | 10 | $284 |
| Novartis Pharmaceuticals Corporation NVS | 11 | $283 |
| Abbvie Inc. ABBV | 8 | $209 |
| Karyopharm Therapeutics Inc. KPTI | 5 | $168 |
| Pfizer Inc. PFE | 6 | $147 |
| E.R. Squibb & Sons, L.L.C. BMY | 8 | $137 |
| Janssen Biotech, Inc. JNJ | 5 | $130 |
| Regeneron Healthcare Solutions, Inc. REGN | 3 | $98.58 |
| Takeda Pharmaceuticals U.S.A., Inc. TAK | 4 | $98.23 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.